Ningxia Zhongke Biotechnology Co., Ltd., commonly referred to as Zhongke Biotech, is a leading player in the biotechnology industry, headquartered in the Ningxia Hui Autonomous Region of China. Established in 2001, the company has made significant strides in the development and production of high-quality natural products, particularly in the fields of health supplements and functional foods. Zhongke Biotech is renowned for its innovative offerings, including goji berry extracts and other herbal products, which are distinguished by their purity and efficacy. With a strong commitment to research and development, the company has positioned itself as a trusted name in the global market, catering to both domestic and international clients. Its dedication to quality and sustainability has earned Zhongke Biotech a notable reputation, making it a key player in the biotechnology sector.
How does Ningxia Zhongke Biotechnology Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ningxia Zhongke Biotechnology Co., Ltd's score of 7 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ningxia Zhongke Biotechnology Co., Ltd, headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Ningxia Zhongke Biotechnology Co., Ltd does not appear to have established any formal commitments to reduce carbon emissions or engage in climate initiatives at this time. The lack of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the biotechnology industry, companies are increasingly expected to adopt transparent climate commitments and set measurable targets to mitigate their environmental impact. However, without specific data or commitments, it is challenging to assess Ningxia Zhongke Biotechnology Co., Ltd's position within this evolving landscape.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ningxia Zhongke Biotechnology Co., Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

